
FDA Approves Sarilumab for the Treatment of Adults with Glucocorticoid-Resistant PMR

Glucocorticoid Use May Result in Loss of Bone Mineral Density

ACR Releases New Vaccination Guideline
Sarilumab Approved for the Treatment of Adults with Glucocorticoid-Resistant PMR

Cardiovascular Safety with RA Treatments

Glucocorticoids May Decrease White Matter Integrity & Change Gray Matter Volume

FDA Approves Abaloparatide to Treat Men with Osteoporosis & a High Risk of Fracture
FDA Revokes Emergency Use Authorization for Evusheld

First Biosimilar to Adalimumab Enters the U.S. Market After Years of Legal Battles
- 1
- 2
- 3
- …
- 123
- Next Page »